Bionex Pharmaceuticals, LLC

East Brunswick, NJ 08816

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.24MM
First Award Date 08/01/08
Most Recent Award Date 08/01/16

Key Personnel

Last Name Name Awards Contact
Tan Hock Seng Tan 6

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 08/01/16 - 01/31/17

Pain is the single greatest cause of disability, and its management remains one of medicine?s foremostchallenges. Potent opiates can effectively reduce the severity of pain, thereby diminishing patientsuffering. Unfortunately, chronic use of these drugs can be harmful to patients, whether by inadvertentoverdosing, unintentional addiction, or abu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/01/13 - 08/31/14

DESCRIPTION (provided by applicant): The proposed SBIR Phase II project aims at developing a new drug product, the naltrexone orally dissolving film (ODF), for treatment of alcohol dependence. The naltrexone ODF is a small, thin, and flexible film, containing naltrexone hydrochloride and other excipients. It is applied intra-orally and adheres t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/10/12 - 08/31/13

DESCRIPTION (provided by applicant): The proposed SBIR Phase II project aims at developing a new drug product, the naltrexone orally dissolving film (ODF), for treatment of alcohol dependence. The naltrexone ODF is a small, thin, and flexible film, containing naltrexone hydrochloride and other excipients. It is applied intra-orally and adheres t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 09/30/09 - 06/30/10

DESCRIPTION (provided by applicant): This proposed SBIR Phase I project will demonstrate the feasibility of developing a novel oral transmucosal drug delivery method and dosage form for alcohol dependence treatment. The proposed system is a small, thin, and flexible film, containing the treatment drug, naltrexone. It is applied intra-orally to a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 08/01/08 - 07/30/09

DESCRIPTION (provided by applicant): RESEARCH PROPOSED: Research is proposed to investigate the feasibility of design and fabrication of an oral transmucosal drug delivery system for systemic delivery of nicotine. The drug delivery system is intended to attain a dual drug-release profile so that dual pharmacological actions, i.e., an initial rap...